A new study found a link between NovoNordisk’s blockbuster drug Ozempic and a reduced risk of Alzheimer’s disease. 23andMe, ...

Me (ME), the company that popularized consumer genetic testing, is facing significant financial and leadership challenges as ...

Over the past year, 23andMe set new corporate governance lows. CEO Anne Wojcicki now enters de facto “founder mode” after a ...

Once worth $6 billion, 23andMe has lost 98% of its value and is on the verge of being delisted from the Nasdaq. So what ...

Me was one of the hottest startups of the 2000s, once valued at $6 billion. The company's DNA test kits became a viral ...

Me faces potential bankruptcy, raising concerns about the security of the genetic data of its 15 million customers and the ...

Me continues to face challenges in maintaining its revenue and captures growth. Click here to read why ME stock is a Sell.

Biotech company 23andMe was once hailed as one of the most successful businesses selling DNA analysis services to anybody who ...

Netflix is accused of revealing that three women were the secret children of an Indiana fertility doctor, without their ...

After four decades of searching, a Michigan woman traveled thousands of miles to Southwest Florida to meet the family she ...

The genetic testing company 23andMe, known for providing DNA analysis to millions of customers, is facing bankruptcy, raising ...

A giant biotechnology company might be about to go bust. What will happen to the millions of people’s DNA it holds?